Fairfield, Bush & Co’s Pfizer PFE Stock Holding History

Fairfield, Bush & Co’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$689K	Sell	24,553 -853	-3%	-$22.7K	0.38%	58
2025 Q4	$633K	Sell	25,406 -4,604	-15%	-$116K	0.33%	65
2025 Q3	$765K	Sell	30,010 -2,245	-7%	-$55.4K	0.39%	61
2025 Q2	$782K	Sell	32,255 -1,595	-5%	-$37.2K	0.44%	58
2025 Q1	$858K	Sell	33,850 -814	-2%	-$21.3K	0.54%	52
2024 Q4	$920K	Buy	34,664 +8,281	+31%	+$225K	0.54%	53
2024 Q3	$764K	Buy	26,383 +6,978	+36%	+$204K	0.45%	55
2024 Q2	$543K	Buy	19,405 +2,277	+13%	+$62.7K	0.33%	62
2024 Q1	$475K	Buy	17,128 +2,091	+14%	+$58K	0.28%	71
2023 Q4	$433K	Hold	15,037	–	–	0.25%	75
2023 Q3	$499K	Sell	15,037 -21,300	-59%	-$753K	0.33%	67
2023 Q2	$1.33M	Buy	36,337 +6,100	+20%	+$237K	0.37%	57
2023 Q1	$1.23M	Buy	30,237 +14,501	+92%	+$626K	0.43%	56
2022 Q4	$806K	Buy	15,736 +66	+0.4%	+$3.16K	0.53%	46
2022 Q3	$686K	Buy	15,670 +200	+1%	+$9.72K	0.48%	50
2022 Q2	$811K	Sell	15,470 -550	-3%	-$28K	0.48%	50
2022 Q1	$829K	Sell	16,020 -299	-2%	-$15.5K	0.42%	53
2021 Q4	$964K	Sell	16,319 -16,250	-50%	-$805K	0.46%	50
2021 Q3	$1.4M	Buy	32,569 +3,421	+12%	+$152K	0.46%	54
2021 Q2	$1.14M	Hold	29,148	–	–	0.31%	67
2021 Q1	$1.06M	Sell	29,148 -500	-2%	-$17.8K	0.3%	69
2020 Q4	$1.09M	Sell	29,648 -1,899	-6%	-$69.7K	0.32%	70
2020 Q3	$1.1M	Hold	31,547	–	–	0.35%	62
2020 Q2	$979K	Hold	31,547	–	–	0.35%	62
2020 Q1	$977K	Buy	31,547 +105	+0.3%	+$3.58K	0.41%	53
2019 Q4	$1.17M	Sell	31,442 -772	-2%	-$27.5K	0.43%	54
2019 Q3	$1.1M	Buy	32,214 +33	+0.1%	+$1.2K	0.38%	56
2019 Q2	$1.32M	Sell	32,181 -402	-1%	-$16K	0.45%	52
2019 Q1	$1.31M	Sell	32,583 -6,680	-17%	-$268K	0.44%	53
2018 Q4	$1.63M	Sell	39,263 -158	-0.4%	-$6.56K	0.56%	43
2018 Q3	$1.65M	Buy	39,421 +5,797	+17%	+$223K	0.46%	51
2018 Q2	$1.16M	Sell	33,624 -8,740	-21%	-$299K	0.34%	59
2018 Q1	$1.43M	Sell	42,364 -6,324	-13%	-$217K	0.41%	54
2017 Q4	$1.67M	Buy	48,688 +6,113	+14%	+$208K	0.46%	48
2017 Q3	$1.44M	Hold	42,575	–	–	0.45%	49
2017 Q2	$1.36M	Sell	42,575 -1,054	-2%	-$33.2K	0.44%	51
2017 Q1	$1.42M	Sell	43,629 -269	-0.6%	-$8.48K	0.44%	50
2016 Q4	$1.35M	Buy	43,898 +60	+0.1%	+$1.83K	0.44%	51
2016 Q3	$1.41M	Buy	43,838 +10,013	+30%	+$335K	0.46%	50
2016 Q2	$1.13M	Sell	33,825 -580	-2%	-$18.5K	0.39%	51
2016 Q1	$968K	Sell	34,405 -6,903	-17%	-$197K	0.35%	57
2015 Q4	$1.26M	Buy	41,308 +22,028	+114%	+$693K	0.44%	51
2015 Q3	$575K	Sell	19,280 -22,081	-53%	-$708K	0.25%	71
2015 Q2	$1.32M	Sell	41,361 -2,293	-5%	-$74.7K	0.4%	59
2015 Q1	$1.44M	Sell	43,654 -2,039	-4%	-$64.8K	0.42%	58
2014 Q4	$1.35M	Buy	45,693 +896	+2%	+$25.7K	0.39%	58
2014 Q3	$1.26M	Hold	44,797	–	–	0.36%	67
2014 Q2	$1.26M	Buy	44,797 +22,181	+98%	+$632K	0.37%	64
2014 Q1	$689K	Sell	22,616 -927	-4%	-$27.6K	0.32%	51
2013 Q4	$684K	Sell	23,543 -17,649	-43%	-$514K	0.31%	51
2013 Q3	$1.12M	Sell	41,192 -11,357	-22%	-$309K	0.34%	66
2013 Q2	$1.4M	Buy	+52,549	New	+$1.45M	0.71%	35

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Fairfield, Bush & Co's PFE Position: Q1 2026 in Review

Fairfield, Bush & Co reduced its Pfizer (PFE) stake by 3.4% in Q1 2026, selling an estimated $22.7K and leaving 24,553 shares worth $689K. The position accounts for 0.38% of the portfolio, ranked #58.

Fairfield, Bush & Co first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.67M in Q4 2017. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Fairfield, Bush & Co held 24,553 shares of Pfizer worth $689K as of Q1 2026.
Fairfield, Bush & Co sold 853 Pfizer shares in Q1 2026, an estimated $22.7K.
Pfizer made up 0.38% of Fairfield, Bush & Co's portfolio in Q1 2026, its #58 holding.
Fairfield, Bush & Co first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
Fairfield, Bush & Co's Pfizer position peaked at $1.67M in Q4 2017.
2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Fairfield, Bush & Co's 13F filing for Q1 2026, filed 12 May 2026.